Corporate Profile

IMAC Holdings, Inc. owns or manages IMAC Regeneration Centers, which combine life science advancements with traditional medical care for movement-restricting diseases and conditions. It owns or manages outpatient clinics that provide regenerative, orthopedic and minimally invasive procedures and therapies. IMAC’s outpatient medical clinics emphasize its focus around treating sports and orthopedic injuries without surgery or opioids. The centers are currently located in Illinois, Kentucky, Missouri, and Tennessee, with a FDA Registered laboratory and research and development site in Miami, Florida.

Stock Information

Copyright West LLC. Minimum 15 minutes delayed.

Investor Relations

News Releases

16 Aug '19

BRENTWOOD, Tenn , Aug. 16, 2019 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC ) (“IMAC” or the “Company”), a provider of Innovative Medical Advancements and Care, specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, announces financial

13 Aug '19

BRENTWOOD, Tenn. , Aug. 13, 2019 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc.   (Nasdaq: IMAC ) , a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, announces its BioFirma subsidiary has received

29 Jul '19

BRENTWOOD, Tenn , July 29, 2019 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc.   (Nasdaq: IMAC ) , a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, announces that Ian White , Ph.D., the Company's

20 Jun '19

IMAC executive shares innovative, cost-effective treatment strategies and long-term outcome data for musculoskeletal conditions during presentation to Fortune 500 company representatives and health value industry pioneers BRENTWOOD, Tenn , June 20, 2019 (GLOBE NEWSWIRE) --   IMAC Holdings, Inc. 

Recent Events

Featured Documents

More information coming soon.